SARS coronavirus and innate immunity (WP4912)
Homo sapiens
SARS-CoV triggers the hosts innate immune system via the type I interferon system in dendritic cells and macrophages, which activate ISRE and IFN-b sentitive promoter elements.
Authors
Friederike Ehrhart , Egon Willighagen , Lauren J. Dupuis , John Figueira Hasbun , Eric Weitz , and Aishwarya IyerActivity
Discuss this pathway
Check for ongoing discussions or start your own.
Cited In
- A Chinese host genetic study discovered IFNs and causality of laboratory traits on COVID-19 severity (2021).
- Combination of Enrichment Using Gene Ontology and Transcriptomic Analysis Revealed Contribution of Interferon Signaling to Severity of COVID-19 (2022).
- Longitudinal Neuropathological Consequences of Extracranial Radiation Therapy in Mice (2024).
Are you planning to include this pathway in your next publication? See How to Cite and add a link here to your paper once it's online.
Organisms
Homo sapiensCommunities
COVID-19Annotations
Pathway Ontology
type I interferon signaling pathwayDisease Ontology
Coronavirus infectious disease severe acute respiratory syndrome viral infectious diseaseReferences
- Inhibition of Beta interferon induction by severe acute respiratory syndrome coronavirus suggests a two-step model for activation of interferon regulatory factor 3. Spiegel M, Pichlmair A, Martínez-Sobrido L, Cros J, García-Sastre A, Haller O, et al. J Virol. 2005 Feb;79(4):2079–86. PubMed Europe PMC Scholia
- SARS coronavirus and innate immunity. Frieman M, Heise M, Baric R. Virus Res. 2008 Apr;133(1):101–12. PubMed Europe PMC Scholia